| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.24 | 2e-06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.23 | 4e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 6e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |